Press Release ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) 2 hours ago
Press Release ORICĀ® Pharmaceuticals Reports Second Quarter 2026 Financial Results and Operational Updates Aug 3